A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.